Renishaw plc
Board Changes
Renishaw plc, the global provider of manufacturing technologies, analytical instruments and medical devices, announces the following Board changes.
Sir David McMurtry has informed the Board of his wish to step down as the Company's Executive Chairman. He founded the Company with John Deer over 50 years ago and has been instrumental in driving the success of the business both as Chief Executive and as Executive Chair. He will remain on the Board as a Non-Executive Director continuing to provide specific expertise on product innovation. Sir David Grant, the Senior Independent Director, will assume the role of Interim Non-Executive Chairman whilst the Board commences a process to appoint a permanent successor.
The Company is also pleased to announce that Sir David McMurtry's son, Richard McMurtry, will be appointed as an additional Non-Executive Director. Richard is a highly experienced director of various businesses and an investor who supports start-up companies committed to developing the future of innovation in the UK. He trained as an engineer with significant involvement in product development and robotic systems.
Sir David McMurtry will also step down from the Nomination Committee, with Sir David Grant taking on the role of Chair of this committee. In light of his new responsibilities, Sir David Grant will step down from the Audit and Remuneration Committees.
In addition to the above changes, the Company is currently undertaking a search for an additional Independent Non-Executive Director to join the Board.
These changes are expected to be effective from 1 July 2024, subject to necessary approvals.
There are no disclosures required in respect of Richard McMurtry's appointment under LR.9.6.13.
Karen Atterbury
Interim Company Secretary
13 June 2024
Renishaw plc |
|
Registered office: | New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR |
Registered number: | 01106260, England and Wales |
Telephone: | +44 (0)1453 524524 |
Website: |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.